Hyperlipidemia Clinical Trial
Official title:
Effects of Nonsurgical Periodontal Therapy on Biomarkers in Serum and Gingival Crevicular Fluid in Severe Periodontitis (Stage III/IV) and Hyperlipidemia:A Cohort Study
This study was a single-center, non-randomized, parallel-group design clinical trial, and each group was assigned a 1:1 ratio with or without hyperlipidemia. Both groups underwent periodontal non-surgical treatment, and blood and gingival crevicular fluid were collected before surgery, 1 month and 3 months after surgery for the detection of MCP-1, IL-8, oxLDL, TNF-α, TG, LDL-C, HDL-C.
Status | Recruiting |
Enrollment | 64 |
Est. completion date | November 1, 2023 |
Est. primary completion date | November 1, 2023 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years to 80 Years |
Eligibility | Inclusion Criteria: - Subjects had to meet at least one of the following criteria for the diagnosis of hyperlipidemia: triglyceride (TRG) levels >2.26 mmol/L; high density lipoprotein cholesterol (HDL-C) levels <1.04 mmol/L; or low density lipoprotein cholesterol (LDL-C) levels >4.14 mmol/L - Patients with severe periodontitis (stage III/IV) with probing depth (PD) = 6 mm at at least six sites, at least two multi-rooted or two single-rooted teeth in at least one quadrant, and extended bone loss on imaging to the middle or top third of the root. Periodontitis results in the loss of less than or equal to four teeth. Exclusion Criteria: - systemic illnesses - pregnancy or lactation - systemic antibiotics taken within the previous 6 months - use of cholesterol reduction medication during the past 6 months - subgingival scaling and root planing or surgical periodontal therapy in the last year - chewing smokeless tobacco, smoking pipes or cigars 1 or more times per week, or smoking more than 20 cigarettes per week (1 pack per week) in the past 6 months |
Country | Name | City | State |
---|---|---|---|
China | 2nd Affiliated Hospital, School of Medicine, Zhejiang University | Hangzhou | Zhejiang |
Lead Sponsor | Collaborator |
---|---|
Second Affiliated Hospital, School of Medicine, Zhejiang University |
China,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | monocyte chemotactic protein-1,MCP-1 | Concentration of MCP-1 in gingival crevicular fluids | Before surgery | |
Primary | monocyte chemotactic protein-1,MCP-1 | Concentration of MCP-1 in gingival crevicular fluids | 1 month after surgery | |
Primary | monocyte chemotactic protein-1,MCP-1 | Concentration of MCP-1 in gingival crevicular fluids | 3 months after surgery | |
Primary | oxidized low-density lipoprotein cholesterol, oxLDL | Concentration of oxLDL in gingival crevicular fluids and serum | Before surgery | |
Primary | oxidized low-density lipoprotein cholesterol, oxLDL | Concentration of oxLDL in gingival crevicular fluids and serum | 1 month after surgery | |
Primary | oxidized low-density lipoprotein cholesterol, oxLDL | Concentration of oxLDL in gingival crevicular fluids and serum | 3 months after surgery | |
Secondary | interleukin-8,IL-8 | Concentration of IL-8 in gingival crevicular fluids | Before surgery | |
Secondary | interleukin-8,IL-8 | Concentration of IL-8 in gingival crevicular fluids | 1 month after surgery | |
Secondary | interleukin-8,IL-8 | Concentration of IL-8 in gingival crevicular fluids | 3 months after surgery | |
Secondary | triglycerides,TG | Concentration of TG in serum | Before surgery | |
Secondary | triglycerides,TG | Concentration of TG in serum | 1 month after surgery | |
Secondary | triglycerides,TG | Concentration of TG in serum | 3 months after surgery | |
Secondary | low-density lipoprotein cholesterol,LDL-C | Concentration of LDL-C in serum | Before surgery | |
Secondary | low-density lipoprotein cholesterol,LDL-C | Concentration of LDL-C in serum | 1 month after surgery | |
Secondary | low-density lipoprotein cholesterol,LDL-C | Concentration of LDL-C in serum | 3 months after surgery | |
Secondary | high-density lipoprotein cholesterol,HDL-C | Concentration of HDL-C in serum | Before surgery | |
Secondary | high-density lipoprotein cholesterol,HDL-C | Concentration of HDL-C in serum | 1 month after surgery | |
Secondary | high-density lipoprotein cholesterol,HDL-C | Concentration of HDL-C in serum | 3 months after surgery | |
Secondary | probing depth,PD | The distance (mm) from the bottom of the periodontal pocket to the gingival margin was measured with a periodontal probe (UNC-15, Hu-Friedy, Chicago, IL) parallel to the long axis of the tooth. The mesial, median and distal 6 sites of the labial (buccal) and lingual surfaces were recorded for each tooth. | Before surgery | |
Secondary | probing depth,PD | The distance (mm) from the bottom of the periodontal pocket to the gingival margin was measured with a periodontal probe (UNC-15, Hu-Friedy, Chicago, IL) parallel to the long axis of the tooth. The mesial, median and distal 6 sites of the labial (buccal) and lingual surfaces were recorded for each tooth. | 1 month after surgery | |
Secondary | probing depth,PD | The distance (mm) from the bottom of the periodontal pocket to the gingival margin was measured with a periodontal probe (UNC-15, Hu-Friedy, Chicago, IL) parallel to the long axis of the tooth. The mesial, median and distal 6 sites of the labial (buccal) and lingual surfaces were recorded for each tooth. | 3 months after surgery | |
Secondary | clinical attachment level,CAL | The periodontal probe measures the distance (mm) from the bottom of the gingival sulcus or the bottom of the periodontal pocket to the cementoenamel boundary. The mesial, median and distal 6 points of the labial (buccal) and lingual surfaces were recorded for each tooth. | Before surgery | |
Secondary | clinical attachment level,CAL | The periodontal probe measures the distance (mm) from the bottom of the gingival sulcus or the bottom of the periodontal pocket to the cementoenamel boundary. The mesial, median and distal 6 points of the labial (buccal) and lingual surfaces were recorded for each tooth. | 1 month after surgery | |
Secondary | clinical attachment level,CAL | The periodontal probe measures the distance (mm) from the bottom of the gingival sulcus or the bottom of the periodontal pocket to the cementoenamel boundary. The mesial, median and distal 6 points of the labial (buccal) and lingual surfaces were recorded for each tooth. | 3 months after surgery | |
Secondary | percentage of bleeding on probing,BOP% | Gently probe to the bottom of the bag or gingival sulcus, take out the probe and observe for 10-15 seconds to see if there is any bleeding. The mesial, median and distal 6 sites of the labial (buccal) and lingual surfaces were recorded for each tooth. Calculate the percentage of bleeding sites. | Before surgery | |
Secondary | percentage of bleeding on probing,BOP% | Gently probe to the bottom of the bag or gingival sulcus, take out the probe and observe for 10-15 seconds to see if there is any bleeding. The mesial, median and distal 6 sites of the labial (buccal) and lingual surfaces were recorded for each tooth. Calculate the percentage of bleeding sites. | 1 month after surgery | |
Secondary | percentage of bleeding on probing,BOP% | Gently probe to the bottom of the bag or gingival sulcus, take out the probe and observe for 10-15 seconds to see if there is any bleeding. The mesial, median and distal 6 sites of the labial (buccal) and lingual surfaces were recorded for each tooth. Calculate the percentage of bleeding sites. | 3 months after surgery |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00001154 -
Lipoprotein Metabolism in Normal Volunteers and Patients With High Levels of Lipoproteins
|
||
Completed |
NCT02927184 -
Safety and Tolerability of VK2809 in Patients With Primary Hypercholesterolemia and Non-Alcoholic Fatty Liver Disease
|
Phase 2 | |
Completed |
NCT04640012 -
Ascending-Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics of DC371739 Single-Dose Treatment in Healthy Subjects
|
Phase 1 | |
Completed |
NCT03213288 -
Bilberry Fruit and Black Rice Derived Anthocyanins on Lipid Status
|
N/A | |
Completed |
NCT00382564 -
Magnetic Resonance Angiography to Diagnose Atherosclerotic Disease
|
N/A | |
Recruiting |
NCT02979704 -
A Comparative Study of Rosuvastatin and Atorvastatin in Patients With Hyperlipidemia
|
Phase 2/Phase 3 | |
Completed |
NCT02569814 -
A Study to Compare the Pharmacokinetics and Safety of a Fixed Dose Combination of Fimasartan/Amlodipine/Rosuvastatin
|
Phase 1 | |
Completed |
NCT02280590 -
Comparison of the Efficacy and Safety of Cresnon® and Crestor® in Patients With Hyperlipidemia
|
Phase 4 | |
Completed |
NCT02428998 -
Safety for 24 Weeks Intake of Korean Red Ginseng in Adults
|
N/A | |
Completed |
NCT01678183 -
Financial Incentives for Medication Adherence
|
N/A | |
Completed |
NCT01426412 -
A Study of LY3015014 in Healthy Participants With Elevated Low Density Lipoprotein Cholesterol
|
Phase 1 | |
Completed |
NCT01694446 -
Regulation of Intestinal and Hepatic Lipoprotein Production by Glucose and Fructose
|
N/A | |
Completed |
NCT01131832 -
Genetic Basis for Heterogeneity in Response of Plasma Lipids to Plant Sterols
|
Phase 4 | |
Completed |
NCT00534105 -
Lipid Metabolism in Gestational Diabetes
|
N/A | |
Completed |
NCT00758303 -
A Study to Evaluate the Lipid Regulating Effects of TRIA-662
|
Phase 2/Phase 3 | |
Recruiting |
NCT00408824 -
Investigation of Genetic Risk of Metabolic Syndrome in Company Employee (NGK Study)
|
N/A | |
Terminated |
NCT00299169 -
Randomized Trial Comparing N of 1 Trials to Standard Practice to Improve Adherence to Statins in Patients With Diabetes
|
Phase 4 | |
Completed |
NCT00362206 -
Comparison of the Combination of Fenofibrate and Simvastatin Versus Pravastatin
|
Phase 3 | |
Completed |
NCT00381992 -
Risk Assessment of Long-Haul Truck Drivers
|
N/A | |
Completed |
NCT00701454 -
Survey of Thai-Muslim Health Status
|
N/A |